SEARCH

SEARCH BY CITATION

REFERENCES

  • Abelson JL, Khan S, Liberzon I, Young EA. 2007. HPA axis activity in patients with panic disorder: Review and synthesis of four studies. Depress Anxiety 241:6676.
  • Anisman H, Merali Z, Stead JD. 2008. Experiential and genetic contributions to depressive- and anxiety-like disorders: Clinical and experimental studies. Neurosci Biobehav Rev 32:11851206.
  • Bailey JE, Papadopoulos A, Diaper A, Phillips S, Schmidt M, van der Ark P, Dourish CT, Dawson GR, Nutt DJ. 2011. Preliminary evidence of anxiolytic effects of the CRF1 receptor antagonist R317573 in the 7.5% CO2 proof-of-concept experimental model of human anxiety. J Psychopharmacol 25:11991206.
  • Bale TL. 2005. Sensitivity to stress: Dysregulation of CRF pathways and disease development. Horm Behav 48:110.
  • Bale TL, Vale WW. 2004. CRF and CRF receptors: Role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525557.
  • Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263265.
  • Bradley R, Binder E, Epstein M, Tang Y, Nair H, Liu W, Gillespie C, Berg T, Evces M, Newport J, Stowe Z, Heim C, Nemeroff C, Schwartz A, Cubells J, Ressler K. 2008. Influence of child abuse on adult major depressive disorder: Moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 65:190200.
  • Carroll BJ, Cassidy F, Naftolowitz D, Tatham NE, Wilson WH, Iranmanesh A, Liu PY, Veldhuis JD. 2007. Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand Suppl 433:90103.
  • Charney DS, Drevets WD. 2002. Neurobiological basis of anxiety disorders. In: Davis KL, Charney D, Coyle JT, et al., editors. Neuropsychopharmacology: The fifth generation of progress. Baltimore, MD: Lippincott Williams & Wilkins. pp 901930.
  • Choi SH, Kim SJ, Park SH, Moon BH, Do E, Chun BG, Lee MS, Shin KH. 2005. Doxapram increases corticotropin-releasing factor immunoreactivity and mRNA expression in the rat central nucleus of the amygdala. Peptides 26:22462251.
  • Grabe HJ, Schwahn C, Appel K, Mahler J, Schulz A, Spitzer C, Fenske K, Barnow S, Lucht M, Freyberger HJ, John U, Teumer A, Wallaschofski H, Nauck M, V€olzke H. 2010. Childhood maltreatment, the corticotropin releasing hormone receptor gene and adult major depressive disorder in the general population. Am J Med Genet Part B 153B(1):14831493.
  • Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. 2006. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: New molecular targets. CNS Neurol Disord Drug Targets 5:453479.
  • Hodges LM, Weissman MM, Haghighi F, Costa R, Bravo O, Evgrafov O, Knowles JA, Fyer AJ, Hamilton SP. 2009. Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder. Am J Med Genet Part B 150B:6573.
  • Isogawa K, Nagayma H, Tsutsumi T, Kiyota A, Akiyoshi J, Hieda K. 2005. Simultaneous use of thyrotropin-releasing hormone test and combined dexamethasone/corticotropine-releasing hormone test for severity evaluation and outcome prediction in patients with major depressive disorder. J Psychiatr Res 39:467473.
  • Keck ME, Kern N, Erhardt A, Unschuld PG, Ising M, Salyakina D, Müller MB, Knorr CC, Lieb R, Hohoff C, Krakowitzky P, Maier W, Bandelow B, Fritze J, Deckert J, Holsboer F, Müller-Myhsok B, Binder EB. 2008. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet Part B 147B:11961204.
  • Kellner M, Wiedemann K. 1998. Nonresponse of adrenocorticotropic hormone in first ever lactate-induced panic attacks in healthy volunteers. Arch Gen Psychiatry 551:8586.
  • Ku YH, Tan L, Li LS, Ding X. 1998. Role of corticotropin releasing factor and substance P in press or responses of nuclei controlling emotion and stress. Peptides 19:677682.
  • Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S. 2003. Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 228:21692178.
  • Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. 2009. A partitionligation–combination–subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis (http://analysis.bio-x.cn). Cell Res 19:519523.
  • Liu Z, Zhu F, Wang G, Xiao Z, Wang H, Tang J, Wang X, Qiu D, Liu W, Cao Z, Li W. 2006. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci Lett 404:358362.
  • Nemeroff CB, Vale WW. 2005. The neurobiology of major depressive disorder: Inroads to treatment and new drug discovery. J Clin Psychiatry 66:513.
  • Nemeroff CB, Krishnan KR, Reed D, Leder R, Beam C, Dunnick NR. 1992. Adrenal gland enlargement in major depression. A computed tomographic study. Arch Gen Psychiatry 49:384387.
  • Papiol S, Arias B, Gastó C, Gutiérrez B, Catalán R, Fañanás L. 2007. Genetic variability at HPA axis in major depressive disorder and clinical response to antidepressant treatment. J Affect Disord 104:8390.
  • Perrin MH, Grace CR, Riek R, Vale WW. 2006. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: Sushi domains and the B1 family of G protein-coupled receptors. Ann N Y Acad Sci 1070:105119.
  • Pintor L, Torres X, Navarro V, Martinez de Osaba MA, Matrai S, Gastó C. 2007. Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: A comparative study. Prog Neuropsychopharmacol Biol Psychiatry 31:10271033.
  • Polanczyk G, Caspi A, Williams B, Price TS, Danese A, Sugden K, Uher R, Poulton R, Moffitt TE. 2009. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: Replication and extension. Arch Gen Psychiatry 66:978985.
  • Preter M, Klein DF. 2008. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry 323:603612.
  • Risbrough VB, Stein MB. 2006. Role of corticotrophin releasing factor in anxiety disorders: A translational research perspective. Horm Behav 50:550561.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl.):2233.
  • Shi YY, He L. 2005. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:9798.
  • Simon NM, Fischmann D. 2005. The implications of medical and psychiatric comorbidity with panic disorder. J Clin Psychiatry 66:815.
  • Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W, Lee KF. 1998. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:10931102.
  • Swaab DF, Bao AM, Lucasson PJ. 2005. The stress system in the human brain in major depressive disorder and neurogeneration. Ageing Res Rev 4:141194.
  • Tharmalingam S, King N, De Luca V, Rothe C, Koszycki D, Bradwejn J, Macciardi F, Kennedy JL. 2006. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. Psychiatr Genet 16:9397.
  • Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W. 1998. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162166.
  • Tyrka AR, Price LH, Gelernter J, Schepker C, Anderson GM, Carpenter LL. 2009. Interaction of childhood maltreatment with the corticotrophin releasing hormone receptor gene: Effects on hypothalamic–pituitary–adrenal axis reactivity. Biol Psychiatry 66:681685.
  • Villafuerte SM, Del-Favero J, Adolfsson R, Souery D, Massat I, Mendlewicz J, Van Broeckhoven C, Claes S. 2002. Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depressive disorder. Am J Med Genet 114:222226.
  • Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. 2006. The dex/CRH test—Is it better than the DST? Psychoneuroendocrinology 31:889894.